National Cancer Institute: Pioneering Innovations for Enhanced Public Health

National Cancer Institute: Pioneering Innovations for Enhanced Public Health

The Motamed Cancer Institute has recently been elevated to the status of the Iranian National Cancer Institute, marking a significant milestone in cancer research and public health improvement in Iran. This transition reflects the institute’s commitment to enhancing the well-being of society through innovative solutions and advanced cancer care.

During a press conference on October 13, coinciding with Breast Cancer Awareness Month, key representatives from the institute announced the launch of the 7th Nationwide Campaign on Screening for Common Cancers in Women. The event featured prominent figures including Dr. Zahra Sheikhi, Deputy for Research and Technology of the Academic Center for Education, Culture and Research (ACECR), and Dr. Ramin Sarrami Foroushani, President of the Motamed Cancer Research Institute.

Dr. Sarrami-Foroushani emphasized the importance of this elevation, stating that this achievement is the culmination of three decades of dedicated work by ACECR scientists and researchers. He noted that the center’s new structure comprises:

  • Research Institute for Regenerative Medicine and Advanced Cancer Therapies
  • Research Institute for Converging Technologies in Cancer
  • Research Institute for Personalized Medicine and Quality of Life

Overall, the National Cancer Research Institute will include around 10 specialized research departments aimed at developing innovative technologies in cancer care. Dr. Sarrami-Foroushani expressed optimism that with ongoing support from national authorities, the institute would emerge as a leading hub for cancer research in Iran.

Cancer Innovation Tower Project

In addition to the elevation announcement, Dr. Sarrami-Foroushani disclosed plans for a new 15-storey cancer innovation tower in Tehran, designed to support advanced therapy ecosystems. This project has garnered strong backing from the Iranian Parliament, particularly the Health Commission, as well as the Plan and Budget Organization and the Vice-Presidency for Science, Technology, and Knowledge-Based Economy.

Funding for the project has already been secured, and the upper levels of the tower will focus on producing innovative technologies for advanced cancer treatments. Dr. Sarrami-Foroushani maintained that while technological progress is crucial, preserving ACECR’s cultural identity remains a core value. He stated, “While focusing on innovation, we continue to embed cultural principles in all our scientific and health-related initiatives.”

National Program for Early Cancer Detection

The institute is also moving forward with a national program aimed at early cancer detection, leveraging nearly 30 years of experience in cancer screening and diagnosis. Dr. Sarrami-Foroushani reflected on the institute’s beginnings as a small clinic on Shahid Nazari Street, at a time when early detection was not widely understood or implemented in Iran.

Today, the institute’s mission has expanded into a comprehensive, nationwide program in collaboration with ACECR’s research, healthcare, and cultural divisions. The establishment of the National Cancer Research Institute represents a significant transformation from a small clinic to a leading scientific and technological center focused on public health improvement.

As part of its initiatives, the institute announced the launch of the National Breast Cancer Awareness Campaign, coinciding with Global Breast Cancer Awareness Month. This campaign will operate across three primary areas:

  1. Promotion
  2. Education
  3. Treatment

Through this campaign, the Motamed Cancer Institute aims to provide tangible and accessible health services to the public. Activities will include:

  • Citywide symbolic events
  • Educational workshops for healthcare professionals
  • Free screening and treatment services for diagnosed patients

Dr. Sarrami-Foroushani highlighted the critical importance of early detection, noting that breast cancer is the most prevalent cancer among women worldwide. He stated that early detection significantly improves survival rates and reduces treatment costs. However, he pointed out that the average tumor size at diagnosis in Iran is approximately 32 mm, compared to the global average of 8 mm, which underscores the urgent need for enhanced early detection strategies.

In conclusion, Dr. Sarrami-Foroushani expressed his gratitude to all researchers, clinicians, cultural experts, and volunteers involved in the nationwide campaign. He emphasized that supporting women through education and early detection ultimately strengthens families and society as a whole.

Similar Posts

  • Strengthening Health and Humanitarian Partnerships: IRCS and Tajikistan Explore Collaborative Opportunities

    The Iranian Red Crescent Society (IRCS) is advancing health and humanitarian collaborations, particularly with Tajikistan. In a recent meeting, IRCS head Pirhossein Kolivand and Tajik ambassador Zohidi Nizomiddin Shamsiddinzoda discussed plans to reopen the IRCS center in Tajikistan, emphasizing mutual support for improved health relations. The IRCS is recognized globally for its humanitarian efforts, with a focus on innovative healthcare solutions and addressing climate change impacts. The organization aims to enhance community resilience and provide essential aid, reinforcing its commitment to both Iranian and international populations, particularly in regions with critical health needs.

  • Iranian Universities Plummet in Global Rankings: Unraveling the Causes and Impacts

    The SCImago 2025 ranking highlights a significant decline in the status of Iranian universities, with most institutions facing decreasing ranks over the past four years. Only Tehran Islamic Azad University of Medical Sciences showed slight improvement. Notable declines include Isfahan University of Technology, which dropped 1,019 places, and Shiraz University, which fell 923 places. Key factors contributing to this trend include brain drain, funding shortages, reduced international collaboration, and poor management. The emigration of students and academics is rising, exacerbated by economic and political challenges. Experts suggest reforms and increased investment in research to reverse this decline.

  • Join the Fight: National Campaign Launched to Combat Cancer!

    A nationwide initiative in Iran, running from January 20 to 26, focuses on cancer prevention and treatment, themed ‘hand in hand, prevent and fight against cancer.’ With over 55,000 annual deaths attributed to cancer in Iran, the campaign seeks to raise public awareness, promote early detection, and support patients. It highlights the importance of lifestyle changes and dispelling myths about cancer. Additionally, the initiative aligns with World Cancer Day, emphasizing a people-centered approach to care from 2025 to 2027. The campaign aims to address misconceptions while fostering a supportive health environment to combat rising cancer cases in the country.

  • Minister Calls on WHO to Safeguard Global Health Amid Sanctions Crisis

    Iran’s Health Minister, Mohammad-Reza Zafarqandi, addressed the detrimental impact of sanctions on public health during the WHO Regional Committee for the Eastern Mediterranean (RC72) in Cairo. He described sanctions as “silent wars” that undermine health systems, urging WHO members to protect healthcare from political pressures. Zafarqandi highlighted the challenges Iran faces, worsened by sanctions and conflict, emphasizing the need for regional solidarity to address health crises and climate change. He reaffirmed Iran’s commitment to enhancing healthcare, advocating for collaboration with countries like Saudi Arabia and Egypt to improve health outcomes, particularly in medication manufacturing.

  • Iran’s Innovative Biotech Revolution: Expanding Reach to 35 Global Markets

    Since March 19, 2024, Iran’s biotechnology product exports have expanded to 35 countries, up from 33, showcasing the nation’s growing pharmaceutical biotechnology capabilities. Hossein Amirazodi, from the association of pharmaceutical biotechnology producers, reported these developments at the 4th International Conference on Iranian Medical Biotech Products. The industry saves Iran around $2 billion annually, constituting 60% of pharmaceutical exports, with Iran producing 40 of the 150 global biotechnology products. Additionally, medicine exports reached $104.6 million, a 19.7% increase, with 345 companies involved. Plans to boost pharmaceutical exports by 30% indicate potential growth in Iran’s biotechnology sector.

  • Iran Welcomes 400,000 Authorized Foreign Workers: A Boost to the Economy!

    Recent discussions in Iran have revealed that around 400,000 foreign nationals, primarily from Afghanistan, are legally employed, underscoring their vital role in the labor market. Ali Baqeri from the Ministry of Cooperatives emphasized the necessity for Iranian employers to obtain legal permits for hiring foreign workers. Key regulations include work permit applications, reemployment procedures, and coverage of health insurance for refugees. Iran has launched support programs like the Comprehensive Refugee Registration Plan and family passport initiatives. Despite challenges due to reduced aid, officials assert Iran’s commitment to managing foreign labor and providing services to refugees.